Skip to the page

Data / Form D filings / MAINZ BIOMED N.V.

MAINZ BIOMED N.V.: Form D filings

MAINZ BIOMED N.V., a biotechnology company in Mainz, Germany, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on May 10, 2024, reports $14.3 million sold of a $50 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
ROBERT KOCH STRASSE 50, Mainz, Germany, 55129
Phone
+49-6131-55428-60
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Netherlands
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1874252

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 10, 2024Amendment$50,000,000$14,300,000$35,700,0001Jun 28, 2023sec.gov
Jul 11, 2023New notice$50,000,000$5,500,000$44,500,0001Jun 28, 2023sec.gov
Sep 8, 2021New noticeIndefinite$603,0008Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Phillip FreeseExecutive Officer
Gregory TibbitsDirector
Guido BaechlerExecutive Officer, Director
Alberto LibanoriDirector
Moritz EidensExecutive Officer, Director
Heiner DreismannDirector
Nicole HoldenDirector
Hans HeklandDirector
William CaragolExecutive Officer
Darin LeighExecutive Officer

Every Form D from the week of May 6, 2024 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what MAINZ BIOMED N.V. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.